Join us for a conversation with guest Shelli Pavone, co-founder of Inlightened, to uncover the untapped potential of diversity in clinical trials. Discover how historical mistrust, structural barriers, and exclusion criteria continue to hinder diverse patient recruitment. Shelli sheds light on the transformative impact inclusive trials have on scientific integrity, safety, and the generalizability of results. By embracing diversity, not only do we align with regulatory expectations, but we also pave the way for innovation and trust in our healthcare systems. This episode promises to expand your understanding of why diversity in trial participation is a scientific necessity rather than just a moral obligation.
Explore the importance of diversifying clinical trial staff to boost trial success and enrollment rates. Shelli discusses breaking the mold of traditional investigator homogeneity by incorporating minority physicians, which fosters trust and enhances trial outcomes. Her insights into the creation of Inlightened reveal a passion for revolutionizing access to healthcare expertise, championing diverse voices, and pushing for equitable innovation. Uncover how Enlightened endeavors to challenge the constraints of conventional investment patterns and encourages the industry to embrace ideas that promise greater societal benefits.
This episode covers:
• Exploration of historical mistrust in clinical trials
• Challenges faced in diversifying patient recruitment
• Benefits of having diverse voices in clinical research
• The FDA's evolving stance on diversity in clinical trials
• The role of diverse investigators in influencing patient enrolment
• Strategies to reduce barriers and increase participation
• Shelli's journey and passion for healthcare innovation
• The overarching need for change in the clinical trial landscape
Shelli Pavone: https://www.linkedin.com/in/shelli-pavone-a729b2/
Inlightened: https://getinlightened.com/
________
Reach out to Ivanna Rosendal
Join the conversation on our LinkedIn page